IR780-based light-responsive nanocomplexes combining phase transition for enhancing multimodal imaging-guided photothermal therapy.

Abstract

Near-infrared (NIR) light-triggered photothermal therapy (PTT) has been widely applied for treating cancer. The combination of nanotechnology and NIR has shown great promise for promoting the efficacy of PTT. However, PTT alone could not completely ablate the tumors and easily causes tumor recurrence. To overcome this challenge, many studies have been performed to enhance PTT, including combining chemical therapy and radiotherapy, both of which have side effects on the body. To reduce the side effects and enhance PTT, a new infrared IR780-based nanocomplex combining liquid fluorocarbon perfluoropentane (PFP) has been synthesized for enhancing multimodal imaging-guided PTT. Under NIR irradiation, the size changes of PFP-loaded nanobubbles transforming into microbubbles allow ultrasound (US) imaging, showing boundaries and internal information of tumors. The breakup process and cascade reaction of phase transition can improve intratumoral permeation and retention of nanoparticles in nonmicrovascular tissue and damage the cell membranes of tumors, further enhancing PTT to kill tumor cells. The strong absorption in the NIR field of IR780-loaded NPs allows not only photoacoustic (PA) imaging but also NIR fluorescence (NIRF) imaging, which provides more anatomical information about tumors. This nanocomplex exhibits good biocompatibility and nontoxicity, strong PA/US/NIRF imaging contrast, excellent liquid-gas transition and a photothermal effect. This finding provides a new method to enhance multimodal imaging-guided cancer nanotheranostics.

• Authors: Mingzhu Liu , Ping Zhang , Liming Deng , Dan Guo , Mixiao Tan , Ju Huang , Yuanli Luo , Yang Cao , Zhigang Wang
• Journal: Biomaterials science (Biomater Sci) Vol. 7 Issue 3 Pg. 1132-1146 (Feb 26 2019) ISSN: 2047-4849 [Electronic] England
• PMID: 30648167 (Publication Type: Journal Article)

Chemical References

• 2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindolium
• Indoles
• Oligopeptides
• Polyglactin 910
• arginyl-glycyl-aspartic acid

Topics

• Animals
• Cell Line, Tumor
• Cell Survival (drug effects, radiation effects)
• Hemolysis (drug effects)
• Indoles (chemistry)
• Infrared Rays
• Melanoma, Experimental (diagnostic imaging, pathology, therapy)
• Mice
• Nanoparticles (chemistry, toxicity)
• Oligopeptides (chemistry)
• Phase Transition
• Phototherapy
• Polyglactin 910 (chemistry)
• Ultrasonography